Litcius/Paper detail

Pulmonary surfactant itself must be a strong defender against SARS-CoV-2

Takano Hideyuki

2020Medical Hypotheses43 citationsDOIOpen Access PDF

Topics & Concepts

Pulmonary surfactantLungPneumoniaReceptorCoronavirusImmunologyVirusVirologyChemistryCoronavirus disease 2019 (COVID-19)BiologyMedicinePathologyInternal medicineDiseaseBiochemistryInfectious disease (medical specialty)Neonatal Respiratory Health ResearchRespiratory Support and MechanismsInhalation and Respiratory Drug Delivery
Pulmonary surfactant itself must be a strong defender against SARS-CoV-2 | Litcius